Reverse white-coat effect as an independent risk for left ventricular concentric hypertrophy in patients with treated essential hypertension

Journal of Human Hypertension

Volumn 21, Issue 3, 2007, Pages 212-219

  Tomiyama, M ^a   Horio, T ^a   Kamide, K ^a   Nakamura, S ^a   Yoshihara, F ^a   Nakata, H ^a   Nakahama, H ^a   Kawano, Y ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; WHITE COAT HYPERTENSION;

AGED; BLOOD PRESSURE MONITORING, AMBULATORY; COMORBIDITY; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; JAPAN; MALE; REGRESSION ANALYSIS; RISK FACTORS;

EID: 33847069221     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002127     Document Type: Article

References (28)

1. Pickering TG, Harshfield GA, Devereux RB, Laragh JH. What is the role of ambulatory blood pressure monitoring in the management of hypertensive patients? Hypertension 1985; 7: 171-177.
2. Schillaci G, Verdecchia P, Sacchi N, Bruni B, Benemio G, Pede S et al. Clinical relevance of office under-estimation of usual blood pressure in treated hypertension. Am J Hypertens 2000; 13: 523-528.
3. Cuspidi C, Meani S, Fusi V, Valerio C, Catini E, Magrini F et al. Isolated ambulatory hypertension and changes in target organ damage in treated hypertensive patients. J Hum Hypertens 2005; 19: 471-477.
4. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. JAMA 1983; 249: 2792-2798.
5. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999; 282: 539-546.
6. Verdecchia P, Reboldi G, Porcellati C, Schillaci G, Pede S, Bentivoglio M et al. Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects. J Am Coll Cardiol 2002; 39: 878-885.
7. Pickering TG, Davidson K, Gerin W, Schwartz JE. Masked hypertension. Hypertension 2002; 40: 795-796.
8. Wing LMH, Brown MA, Beilin LJ, Ryan P, Reid CM. 'Reverse white-coat hypertension' in older hypertensives. J Hypertens 2002; 20: 639-644.
9. Bombelli M, Sega R, Facchetti R, Corrao G, Friz HP, Vertemati AM et al. Prevalence and clinical significance of a greater ambulatory versus office blood pressure ('reversed white coat' condition) in a general population. J Hypertens 2005; 23: 513-520.
10. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003; 348: 2407-2415.
11. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B et al. Cardiovascular prognosis of 'masked hypertension' detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004; 291: 1342-1349.
12. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-1566.
13. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-352.
14. Hata Y, Mabuchi H, Saito Y, Itakura H, Egusa G, Ito H et al. Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese adults. J Atheroscler Thromb 2002; 9: 1-27.
15. Kawano Y, Matsuoka H, Takishita S, Omae T. Effects of magnesium supplementation in hypertensive patients: Assessment by office, home, and ambulatory blood pressures. Hypertension 1998; 32: 260-265.
16. Imai Y, Sasaki S, Minami N, Munakata M, Hashimito T, Sakuma H et al. The accuracy and performance of the A&D TM 2421, a new ambulatory blood pressure monitoring device based on the cuff-oscillometric and the Korotkoff sound technique. Am J Hypertens 1992; 5: 719-726.
17. Horio T, Miyazato J, Kamide K, Takiuchi S, Kawano Y. Influence of low high-density lipoprotein cholesterol on left ventricular hypertrophand diastolic function in essential hypertension. Am J Hypertens 2003; 16: 938-944.
18. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
19. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367.
20. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: Anatomic validation of the method. Circulation 1977; 55: 613-618.
21. Cifkova R, Erdine S, Fagard R, Farsang C, Heagerty AM, Kiowski W et al. Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens 2003; 21: 1779-1786.
22. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
23. Liu JE, Roman MJ, Pini R, Schwartz JE, Pickering TG, Devereux RB. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med 1999; 131: 564-572.
24. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation 2001; 104: 1385-1392.
25. Tomiyama M, Horio T, Yoshii M, Takiuchi S, Kamide K, Nakamura S et al. Masked hypertension and target organ damage in treated hypertensive patients. Am J Hypertens 2006; 19: 880-886.
26. Björklund K, Lind L, Zethelius B, Andrén B, Lithell H. Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men. Circulation 2003; 107: 1297-1302.
27. Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J et al. Prognosis of 'masked' hypertension and 'white-coat' hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol 2005; 46: 508-515.
28. Pierdomenico SD, Lapenna D, Bucci A, Di Tommaso R, Di Mascio R, Manente BM et al. Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. Am J Hypertens 2005; 18: 1422-1428.